How To Treat Eczema With Cannabis


Cannabis has an ever-growing list of medical applications. In the 29 states with medical marijuana programs, dermatologists are explaining to patients with skin conditions, such as eczema, that cannabis can be an effective, and all-natural treatment. Here’s a definitive guide on how to treat eczema with cannabis.

Eczema: A Brief Overview

Eczema is the overarching name for a variety of dry skin conditions. Namely, eczema includes redness, itchiness and dry patches. It’s often located on joints, hands and feet, but can occur anywhere including the face, scalp and eyelids. Eczema is common in both children and adults, who generally experience sporadic flare-ups.

There is no longterm cure for eczema. Typically, dermatologists recommend using sensitive skincare soaps and moisturizers. Many cases, however, require prescription ointments and creams that often contain steroids.

People develop eczema for a number of reasons, many of which are difficult to detect. Environmental factors, allergies and stress can cause outbreaks. For many with eczema, dry, cracked skin, itchiness and redness are a lifelong issue. Most eczema care is preventative with moisturizing and avoiding certain soaps and toxins.

How Cannabis Can Treat Eczema


According to the National Eczema Association, cannabis can be an effective treatment for eczema. Research demonstrates that cannabinoids have anti-itch, anti-microbial and anti-inflammatory properties–all of which make it an effective tool for coping with eczema.


Cannabis’ use as an eczema treatment goes as far back as Dr. Henry Granger Piffard, the founder of the world-renowned journal, JAMA Dermatology. Dr. Piffard, who lived from 1842 to 1910 was a leader in the study of dermatology.

He writes in the first textbook ever published on dermatological remedies, “a pill of cannabis indica at bedtime has at my hands sometimes afforded relief to the intolerable itching of eczema.”

Cannabis is effective largely because the skin contains cannabinoid receptors. These receptors are part of the endocannabinoid system, a web of neurotransmitters and receptors that exists throughout the whole body. The body’s endocannabinoid system, which has cannabis receptors that interact with other naturally forming cannabinoids, such as those found in cannabis, make’s marijuana such an effective medicine. Through communication with the skin’s cannabinoid receptors, phytocannabinoids found in cannabis can reduce itching and redness.

Cannabis also treats eczema by controlling a bacteria that commonly causes it. Staphylococcus aureus colonization is a normal bacteria found in humans. Its side effects don’t always require treatment, but can lead to severe cases of eczema. According to the National Eczema Association, the most common cannabinoids can control outbreaks of this type of bacteria.


Another benefit of cannabis when it comes to eczema is that topical THC lotions can reduce inflammation. Not only can cannabis reduce the look and itchiness associated with eczema, but it can control the bacteria responsible for the infection. Cannabis’ effectiveness goes beyond homeopathy.

Why Cannabis Is Better Than Traditional Eczema Medication

For some cases of eczema, dermatologists will prescribe steroid creams. Over time, the body builds up a resistance to this type of cream, which means you have to use larger amounts and up the dosage of your prescription.

Steroid cream can thin your skin, and can even cause rosacea. Worse than that, steroid cream can seep into your bloodstream through the skin. This can increase your blood pressure and blood sugar levels and affect your hormones over time.

Steroid cream is not meant for continued use, though it’s often prescribed as an indefinite cure for eczema. This is why knowing how to treat eczema with cannabis could be better for your health in the long run.

How To Treat Eczema With Cannabis Topicals


Just because cannabis can treat eczema doesn’t mean that any cannabis cream will work. People with eczema typically have sensitive skin, which means that certain terpenes can cause skin irritation.

Look for products that are designed for irritated and inflamed skin. Don’t use cannabis topicals made for joint pain, for instance. Stick with something that is mostly CBD rather than THC.

As always, be wary of where you’re buying your topicals. Cannabis regulation is in its infancy, which means that anything could be in your moisturizer. This could include pesticides, heavy metals or other skin irritants. As with any moisturizer or oil you purchase at a drug store, go for the most organic topical you can find.

To avoid something that will aggravate, rather than soothe, your eczema, go to a dispensary rather than buy something online. States with legal medical or recreational marijuana have better regulations. Remember that the FDA has not approved medical marijuana for anything, including eczema.

Final Hit: How To Treat Eczema With Cannabis

Refrain from using steroid cream by treating eczema with all-natural cannabis topicals. Through the interchange between marijuana’s cannabinoids and the endocannabinoid system in the skin, you can reduce inflammation, redness and itchiness. However, take time to research the topicals before trying to remedy any skin condition with cannabis.

Congress Just Extended Federal Medical Marijuana Protections


Congress just extended the federal medical marijuana protections known as the Rohrabacher-Farr amendment, or the Rohrabacher-Blumenauer amendment. It happened early Friday morning when President Donald Trump signed a huge budget deal that brought a short federal shutdown to an end. But these temporary protections still face some uncertainty in the coming months. The latest spending plan only runs until the end of March. At that time, the medical marijuana community could become more volatile at the hands of the Department of Justice.

The Rohrabacher-Farr Amendment Keeps Going


The Rohrabacher-Farr amendment, which prevents Attorney General Sessions from spending tax dollars to prosecute medical marijuana businesses and patients, has been a part of the federal budget for the past few years. In fact, this is the eighth time the rider has been renewed since 2015.

This temporary rider is the only document on the books that protects medical marijuana states. Without it, the U.S Drug Enforcement Administration (DEA) would have free rein to investigate, raid and prosecute all connections to statewide medical marijuana programs.

Congress Riding Same Budget Since 2015

This does not mean Congress has been giving medical marijuana serious consideration during budget talks. It has not. Since Rohrabacher-Farr has been a part of the federal budget for the past three years, it has been gliding on the coattails of the renewal process. Basically, since Congress has not approved a new budget since 2015, the federal medical marijuana protections keep living.

Similar riders have been proposed in the past, but none have ever been given the time of day.


Sessions Pressures Congress to Eliminate Federal Medical Marijuana Protections


It is distinctly possible that the medical marijuana debate will come to a head next month. The current protections are only good until March 23. The Rohrabacher-Farr amendment must find its way inside a much larger budget to maintain. If it will survive the next round of negotiations is anyone’s guess. The protections are at risk for elimination. Attorney General Sessions has been pressuring both the House and Senate to ensure this happens.

It was just last year that Sessions sent a letter to Congressional leaders asking them to abandon support for Rohrabacher-Farr.

“I believe it would be unwise for Congress to restrict the discretion of the Department to fund particular prosecutions, particularly in the midst of a historic drug epidemic and a potentially long-term uptick in violent crime,” Sessions wrote last June. “The Department must be in a position to use all laws available to combat the transnational drug organizations and dangerous drug traffickers who threaten American lives.”

Final Hit: Congress Just Extended Federal Medical Marijuana Protections

Congressional leadership will need to approve the language for inclusion in the new appropriations for the rider to stay intact. Although the Senate has shown some support, the House of Representative has been less than enthusiastic. As NORML political director Justin Strekal pointed out in his analysis, “The provision will now be considered by House and Senate leadership when the two chambers’ appropriations bills are reconciled, should Congress ever set a FY18 budget, of which is already over a third of the way behind us.”

Why states should limit the potency of marijuana


Marijuana legalization states have taken no steps to limit the potency of marijuana, which has increased sharply in recent years. A new study suggests this could create public health problems down the road as more users become addicted or otherwise impaired.

The study was conducted in the Netherlands, where marijuana is legally available through “coffee shops.” The researchers examined the level of delta-9-tetrahydrocannabinol (THC), the main intoxicant in marijuana, over a 16-year period. Marijuana potency more than doubled from 8.6 percent in 2000 to 20.3 percent in 2004, which was followed by a surge in the number of people seeking treatment for marijuana-related problems. When potency declined to 15.3 percent THC, marijuana treatment admissions fell thereafter. The researchers estimated that for every 3 percent increase in THC, roughly one more person per 100,000 in the population would seek marijuana use disorder treatment for the first time.

The Dutch findings are relevant to the United States because high THC marijuana products have proliferated in the wake of legalization. The average potency of legal marijuana products sold in the state of Washington, for example, is 20 percent THC, with some products being significantly higher.

Economy & Business Email Alerts

Breaking news about economic and business issues.

Sign up


Although some people believe prohibiting drugs is what makes their potency increase, the potency of marijuana under legalization has disproved that idea. Potency rises in both legal and illegal markets for the simple reason that it conveys advantages to sellers. More potent drugs have more potential to addict customers, thereby turning them into reliable profit centers.

In other legal drug markets, regulators constrain potency. Legal alcohol beverage concentrations are regulated in a variety of ways, including through different levels of tax for products of different strengths as well as constraints on labeling and place of sale. In most states, for a beverage to be marketed and sold as “beer,” its alcohol content must fall within a specified range. Similarly, if wine is distilled to the point that its alcohol content rises too high, some states require it be sold as spirits (i.e., as “brandy”) and limit its sale locations.

As states have legalized marijuana, they have put no comparable potency restrictions in place, for example capping THC content or levying higher taxes on more potent marijuana strains. Sellers are doing the economic rational thing in response: ramping up potency.


The Dutch results suggest users and the public will suffer from this regulatory gap as more consumers of high-strength marijuana will fall victim to significant ill effects. However, this is an avoidable problem. Government can and should place limits on marijuana’s strength just as it does other addictive products, thereby protecting public health as well as saving the taxpayer the future costs of treatment and other needed health-care services.

How Is Oregon Handling Its Cannabis Surplus?


An overgrowth of weed has lawmakers and spectators alike wondering: how is Oregon handling its cannabis surplus? The state is currently producing more weed than the legal market can handle. And the surplus in cannabis production has become a sticky issue with lawmakers, law enforcement, and cannabis industry players. Here’s how Oregon is handling it.

A Spike In Cannabis Production

Billy J. Williams, the U.S. Attorney for the state of Oregon, published an opinion article last month in The Oregonian. In it, he described the state’s cannabis surplus.

Williams argued that Oregon’s legal weed industry has sparked more marijuana-growing activity than the state can handle. As a result, he said, much of the cannabis produced in Oregon is finding its way onto the black market.

“In 2017 alone, postal agents in Oregon seized 2,644 pounds of marijuana in outbound parcels and over $1.2 million in cash,” he wrote. “Overproduction creates a powerful profit incentive, driving product from both state-licensed and unlicensed marijuana producers into black and gray markets across the country.”

He concluded: “This lucrative supply attracts cartels and other criminal networks into Oregon and in turn brings money laundering, violence, and environmental degradation.”


The massive amount of cannabis being grown in Oregon most likely stems from a couple key factors.

For starters, Oregon has long been a prime location for growing cannabis. Even before weed became legal, growers found near-perfect environmental and climatic conditions for cannabis cultivation.

More recently, the legal industry has likely sparked an uptick in the volume of weed being grown in the state. In particular, Oregon has not set a limit on how many growers can become licensed to produce cannabis.

According to The Chicago Tribune, there are currently 900 licensed recreational growers in Oregon and more than 1,100 waiting approval. There are also more than 25,000 licensed medical marijuana growers.


Given all this activity, it may not be surprising that the state now has more weed than the legal industry can handle.

Final Hit: How Is Oregon Handling Its Cannabis Surplus?

Oregon’s cannabis surplus could create tensions with the federal government. Recently, Attorney General Jeff Sessions revoked an Obama-era policy that directed federal agents to take a “hands-off” approach when dealing with weed-legal states.

The move could pave the way for a federal crackdown. And if such a crackdown materializes, any cannabis perceived to be fueling the black market would be a likely target.

To address this type of tension, Williams is organizing a state-wide summit to discuss how to handle the situation. He said he would invite a wide range of people and organizations to attend.

This includes federal, state, local, and tribal leaders, lawmakers, and law enforcement, public health groups, and various community organizations.

“This summit and the state’s response will inform our federal enforcement strategy,” Williams wrote. “How we move forward will depend in large measure on how the state responds to the gaps we have identified.”


Medical marijuana became legal in Oregon in 1998. Then, in 2014, voters approved the legalization of recreational cannabis. Since then, the state’s legal THC market has exploded.

Now, with a cannabis surplus creating the possibility for increased tension with federal law enforcement, the state may have to adjust key aspects of its legal weed programs.